Drawing for QIQU MEDICAL

USPTO serial 79320216

QIQU MEDICAL

Reviewed by CopyMark Law Group

Reg. 6816972Status 700Registered
Filing date
Status date
Registration date
Aug 16, 2022
Examiner
VAGHANI, MAYUR C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QIQU MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark J. Liss

Mark J. Liss Leydig, Voit & Mayer, Ltd.180 N. Stetson AveSuite 4900Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; non-medicated toiletry preparations; non-medicated skin care preparations; hair preparations and treatments for cosmetic purposes, namely, sprays, gels, and foams; non-medicated scalp care preparations, cosmetic preparations for the scalp; cleaning and cosmetic preparations for protection against contact allergies; cleaning and cosmetic preparations for the prevention of contact allergies; cleaning and cosmetic preparations for the differential stabilisation of skin flora; cosmetic preparations for covering surfaces in the nature of skin for the prevention of contact allergiesACTIVE—
005Medicated preparations for treating skin diseases, including mucous membrane disorders and preparations for treating insect bites; medical plasters, materials for dressings, namely, medical products for healing wounds and alleviating the symptoms of diseased skin in the form of solid, semi-liquid and liquid medicated patches; medical products for healing wounds and alleviating the symptoms of diseased skin, namely, medicated skin care preparations; medicated skin care preparations; medicated skin lotions; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders; biocides; medicated preparations for the treatment and care of wounds, skin injuries, burns and surgical wounds; medicated preparations for protection against contact allergies; medicated preparations for the prevention of contact allergies, medicated preparations for the differential stabilisation of skin flora; transdermal patches for use in the treatment of allergy symptoms; gel for external use, for the medical and therapeutic treatment of allergy symptoms; antimicrobial coatings to treat the growth of viruses, mold, mildew, bacteria and fungus on various surfaces, for the prevention of contact allergiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 21, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 29, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 28, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 16, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 16, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 16, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 11, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 25, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Apr 25, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 25, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 25, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 25, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2022RFNTREFUSAL PROCESSED BY IB—
Jan 31, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 31, 2022RFRRREFUSAL PROCESSED BY MPU—
Jan 11, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 10, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2022DOCKASSIGNED TO EXAMINER—
Sep 24, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 16, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance